Multiplex assays provide attractive time and labor advantages over singleplex ELISA-based assays. In the Luminex assays, a specific antibody to the target protein is covalently coupled to internal ...

instrument and have optimized and provided Luminex assays for cytokines, growth factors, apoptosis, cancer, metabolic markers and Akt and MAP kinase signaling pathways. Commercial vendors are ...

The FlexmiR miRNA product line, developed by Exiqon in collaboration with the Luminex Bioscience Group, constitutes the first commercially available bead-based system for miRNA expression analysis ...

Newly developed techniques include assays that use a multiplex platform, such as the Luminex™, as well as bead assays that use standard flow cytometry. These solid-phase tests can simultaneously ...

Luminex’s xMAP ® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate on which ...

The specificity assay based on flow cytometry contains ... access to transplantation and enhances patient care. Luminex™ single-antigen beads of a patient serum showing the presence of HLA ...

Luminex and Thermo Fisher Scientific are excited to feature two presentations ... DR-SE instrument allow simultaneous detection of several phosphorylated and total proteins on the same bead in a ...